Skip to content

Gross Profit at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%
Stryker logo
StrykerSYK
$3.81B+1.8%
CONMED logo
CONMEDCNMD
$183.45M+3.2%
Enovis logo
EnovisENOV
$365.49M+10.0%
OrthoPediatrics logo
OrthoPediatricsKIDS
$43.39M+13.4%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$47.2M-10.2%
Operating income-$17.2M-10.2%
Net income-$18.0M-12.8%
EPS (diluted)-$0.28-12.0%

Balance sheet

See full
Cash & equivalents$9.5M-28.6%
Total debt$71.6M+3.2%
Total equity$77.2M-26.7%
Total assets$184.1M-10.6%

Cash flow

See full
Operating cash flow$7.2M+72.5%
CapEx$3.1M-13.6%
Free cash flow$4.2M+538%

Valuation

See full
Market cap$258.19M-26.6%
Enterprise value$320.25M-22.6%
P/S1.3×-0.4×

Profitability

See full
Gross margin79.7%-0.5pp
Operating margin-26.9%+2.5pp
Net margin-29.4%+6.1pp
FCF margin-12.5%-2.8pp

Returns & leverage

See full
Return on equity-66.9%+57.5pp
Debt / equity0.9×+0.3×
Current ratio3.6×-0.9×

Where this comes from

Calculated from Treace Medical Concepts, Inc.’s reported figures.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s gross profit?
Treace Medical Concepts, Inc. (TMCI) reported gross profit of $37.41M in Q1 2026.
How has Treace Medical Concepts, Inc.'s gross profit changed year-over-year?
Treace Medical Concepts, Inc.'s gross profit decreased by 10.7% year-over-year, from $41.89M to $37.41M.
What is the long-term trend for Treace Medical Concepts, Inc.'s gross profit?
Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s gross profit has grown at a 21.6% compound annual growth rate (CAGR), from $77.53M to $169.75M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.